These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18296424)

  • 1. Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.
    Shien T; Shimizu C; Akashi-Tanaka S; Yonemori K; Kohno T; Hojo T; Ando M; Katsumata N; Kinoshita T; Fujiwara Y
    Jpn J Clin Oncol; 2008 Mar; 38(3):172-5. PubMed ID: 18296424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
    Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical benefit of S-1 in metastatic breast cancer].
    Saeki T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].
    Taguchi T; Morimoto K; Horikoshi N; Takashima S; Toge T; Kimura M; Sano M; Aoyama H; Ota J; Noguchi S
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1035-43. PubMed ID: 9644319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma.
    Shirao K; Ohtsu A; Takada H; Mitachi Y; Hirakawa K; Horikoshi N; Okamura T; Hirata K; Saitoh S; Isomoto H; Satoh A
    Cancer; 2004 Jun; 100(11):2355-61. PubMed ID: 15160338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.
    Naito S; Tsukamoto T; Usami M; Fujimoto H; Akaza H
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1065-70. PubMed ID: 20157711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A late phase II study of S-1 for metastatic pancreatic cancer.
    Okusaka T; Funakoshi A; Furuse J; Boku N; Yamao K; Ohkawa S; Saito H
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):615-21. PubMed ID: 17520253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.
    Ohtsu A; Baba H; Sakata Y; Mitachi Y; Horikoshi N; Sugimachi K; Taguchi T
    Br J Cancer; 2000 Jul; 83(2):141-5. PubMed ID: 10901361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer.
    Totani Y; Saito Y; Hayashi M; Tada T; Kohashi Y; Mieno Y; Kato A; Imizu H; Yoneda Y; Hoshino T; Uchiyama Y; Takeuchi Y; Okazawa M; Sakakibara H
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1181-5. PubMed ID: 19377885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.
    Ito Y; Osaki Y; Tokudome N; Sugihara T; Takahashi S; Iwase T; Hatake K
    Breast Cancer; 2009; 16(2):126-31. PubMed ID: 18807123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
    Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
    Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of S-1 for advanced gastric cancer after reduction surgery].
    Inaba Y; Hayashi K; Miura T; Moriya T; Takiguchi M; Isobe H; Watabe S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1053-7. PubMed ID: 17637541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of a 2-week S-1 administration followed by 1-week rest for advanced and metastatic breast cancer].
    Fujii K; Kosaka J; Mouri Y; Yoshida M; Yorozuya K; Nakano S; Akizuki M; Fukutomi T; Kobayashi K
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1467-70. PubMed ID: 21918343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.
    Fujitani K; Tsujinaka T; Hirao M
    Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [S-1 activity in non-small cell lung cancer in clinical practice].
    Inagaki M; Onuki T; Iguchi K; Ogata T; Hayashi Y; Saito K; Wakai Y; Takabe K; Shinohara Y; Suzuki K; Ohtani T; Horikoshi K
    Gan To Kagaku Ryoho; 2009 May; 36(5):763-7. PubMed ID: 19461174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
    Hara F; Kiyoto S; Takahashi M; Takabatake D; Takashima S; Aogi K; Ohsumi S; Takashima S
    Oncology; 2010; 79(3-4):273-7. PubMed ID: 21372603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer].
    Yumine K; Kawahara M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():189-92. PubMed ID: 16898000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
    Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T;
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
    Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
    Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.